Free Rhodium (II) citrate and rhodium (II) citrate magnetic carriers as potential strategies for breast cancer therapy

BACKGROUND: Rhodium (II) citrate (Rh(2)(H(2)cit)(4)) has significant antitumor, cytotoxic, and cytostatic activity on Ehrlich ascite tumor. Although toxic to normal cells, its lower toxicity when compared to carboxylate analogues of rhodium (II) indicates Rh(2)(H(2)cit)(4 )as a promising agent for c...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Carneiro, Marcella LB, Nunes, Eloiza S, Peixoto, Raphael CA, Oliveira, Ricardo GS, Lourenço, Luiza HM, da Silva, Izabel CR, Simioni, Andreza R, Tedesco, Antônio C, de Souza, Aparecido R, Lacava, Zulmira GM, Báo, Sônia N
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2011
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3073883/
https://ncbi.nlm.nih.gov/pubmed/21443799
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-3155-9-11
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky